Role of thoracic ultrasonography in pleurodesis pathways for malignant pleural effusions (SIMPLE): an open-label, randomised controlled trial
Journal article
Psallidas I. et al, (2022), The Lancet Respiratory Medicine, 10, 139 - 148
Pleural Fluid Has Pro-Growth Biological Properties Which Enable Cancer Cell Proliferation.
Journal article
Asciak R. et al, (2021), Frontiers in oncology, 11
Patient-derived malignant pleural mesothelioma cell cultures: a tool to advance biomarker-driven treatments
Journal article
Kanellakis NI. et al, (2020), Thorax, 75, 1004 - 1008
Prospective validation of the RAPID clinical risk prediction score in adult patients with pleural infection: the PILOT study
Journal article
Corcoran JP. et al, (2020), European Respiratory Journal, 56, 2000130 - 2000130
Antibiotic Review Kit for Hospitals (ARK-Hospital): study protocol for a stepped-wedge cluster-randomised controlled trial
Journal article
Walker AS. et al, (2019), Trials, 20
Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: evidence from the MIST2 randomised controlled trial.
Journal article
Luengo-Fernandez R. et al, (2019), The European respiratory journal, 54
Early specialist palliative care on quality of life for malignant pleural mesothelioma: a randomised controlled trial
Journal article
Brims F. et al, (2019), Thorax, 74, 354 - 361
Randomised Ambulatory Management of Primary Pneumothorax (RAMPP): protocol of an open-label, randomised controlled trial
Journal article
Hallifax R. et al, (2019), BMJ Open Respiratory Research, 6, e000403 - e000403
Biological effect of tissue plasminogen activator (t-PA) and DNase intrapleural delivery in pleural infection patients.
Journal article
Kanellakis NI. et al, (2019), BMJ open respiratory research, 6
THE BIOLOGICAL EFFECT OF TISSUE PLASMINOGEN (T-PA) ACTIVATOR AND DNASE INTRAPLEURAL DELIVERY IN PLEURAL INFECTION PATIENTS
Conference paper
Kanellakis NI. et al, (2018), THORAX, 73, A243 - A243
The patient perspective of treatment for Malignant Pleural Effusion (MPE)- results of a pilot service-evaluation questionnaire.
Conference paper
Seymour J. et al, (2018), EUROPEAN RESPIRATORY JOURNAL, 52
Development and validation of response markers to predict survival and pleurodesis success in patients with malignant pleural effusion (PROMISE): a multicohort analysis
Journal article
Psallidas I. et al, (2018), The Lancet Oncology, 19, 930 - 939
Randomized Controlled Trial of Urokinase versus Placebo for Nondraining Malignant Pleural Effusion
Journal article
Mishra EK. et al, (2018), American Journal of Respiratory and Critical Care Medicine, 197, 502 - 508
Prospective Validation of The RAPID Clinical Risk Prediction Score in Patients with Pleural Infection: The Pleural Infection Longitudinal Outcome Study (PILOT)
Conference paper
Corcoran JP. et al, (2018), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 197
Survival And Pleurodesis Response Markers In Malignant Pleural Effusion-The Promise Study
Conference paper
Psallidas I. et al, (2018), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 197
Efficacy of sonographic and biological pleurodesis indicators of malignant pleural effusion (SIMPLE): protocol of a randomised controlled trial.
Journal article
Psallidas I. et al, (2017), BMJ open respiratory research, 4
The Third Therapeutic Intervention In Malignant Effusion Trial (time3): A Randomised Controlled Trial To Assess Dyspnea Relief And Pleurodesis Success Following Intrapleural Urokinase In Patients With Non-Draining Malignant Pleural Effusion
Conference paper
Mishra EK. et al, (2016), AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 193
Effect of Opioids vs NSAIDs and Larger vs Smaller Chest Tube Size on Pain Control and Pleurodesis Efficacy Among Patients With Malignant Pleural Effusion
Journal article
Rahman NM. et al, (2015), JAMA, 314, 2641 - 2641
Setting up a respiratory trials unit
Journal article
RAHMAN NM. et al, (2011), Respirology, 16, 64 - 68